Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global RSV Diagnostics Market: By Product: Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADT), Molecular Diagnostics, Others; By End-Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global RSV Diagnostics Market Outlook
The global RSV diagnostics market attained a value of about USD 846.96 million in 2021. The market is further expected to grow at a CAGR of 10.2% during the forecast period of 2022-2027 to reach nearly USD 1516.89 million by 2027.
The Increasing Prevalence of RSV Disease Invigorating the Market Growth of RSV Diagnostics
The global market for RSV diagnostics is being driven by the increasing prevalence of RSV disorder, especially among children below the age of two years. The respiratory syncytial virus is a common and contagious virus that infects the respiratory tract causing breathing problems. Factors such as increasing investments into healthcare infrastructure in conjunction with the rising focus of parents on child medical care are positively impacting the growth of the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
As the symptoms of RSV are similar to other respiratory disorders, the need for rapid, specific, and effective diagnostics is invigorating the growth of the market. Furthermore, the increasing awareness regarding the high survival rates after early diagnosis and the easy availability of diagnostics modalities are further positively influencing the overall market growth of RSV diagnostics. The market is further augmented by favourable government measures, such as reimbursement policies, awareness camps, and free diagnostics, among others.
RSV Diagnostics: Industry Definition and Segmentation
Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which causes asthma, pneumonia, middle ear infections, and sometimes death if left untreated. The diagnostics methods for RSV include blood tests, chest x-rays, checking for white blood cell (WBC) and oxygen levels in the blood, and swab secretions.
On the basis of product, the market can be divided into:
- Direct Fluorescent Antibody (DFA) Method
- Rapid Antigen Diagnostic Test (RADT)
- Molecular Diagnostics
- Chromatographic Immunoassay
- Diagnostic Imaging
- Gel Microdroplets
- Flow Cytometry
- Others
Chromatographic immunoassay can be further divided into gravity driven test and oligochromatography.
Based on end-use, the market can be segmented into:
- Hospitals
- Laboratory
- Clinics
- Homecare
The EMR report looks into the regional markets of RSV diagnostics like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Improved Healthcare Technologies to Propel the Market Growth of RSV Diagnostics
The growth in the global market of RSV diagnostics is expected to be driven by the advent of advanced techniques, including bio-and nanotechnology facilitating the development of modern detection systems for RSV, such as western bolt, enzyme linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). In addition, the nucleic acid amplification techniques and loop-mediated isothermal amplification aligned with point of care (POC) devices are expected to augment the growth of the market in the coming years by allowing testing to be performed using a one-step kit requiring only the addition of a patient sample. In addition to this, fast approvals by the FDA, government and private funding into the healthcare structure, and robust investments into the research and development (R&D) programmes are further expected to drive the market growth of RSV diagnostics over the forecast period.
Key Industry Players in the Global RSV Diagnostics Market
The report presents a detailed analysis of the following key players in the global RSV diagnostics market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Becton, Dickinson and Company
- bioMérieux SA
- DiaSorin Molecular LLC
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2021 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, End-Use, Region |
| Breakup by Product | Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADT), Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Others |
| Breakup by End-Use | Hospitals, Laboratory, Clinics, Homecare |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, bioMérieux SA, DiaSorin Molecular LLC, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global RSV Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global RSV Diagnostics Historical Market (2017-2021)
8.3 Global RSV Diagnostics Market Forecast (2022-2027)
8.4 Global RSV Diagnostics Market by Product
8.4.1 Direct Fluorescent Antibody (DFA) Method
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Rapid Antigen Diagnostic Test (RADT)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Molecular Diagnostics
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Chromatographic Immunoassay
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.4.4 Breakup by Method
8.4.4.4.1 Gravity Driven Test
8.4.4.4.2 Oligochromatography
8.4.5 Diagnostic Imaging
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2017-2021)
8.4.5.3 Forecast Trend (2022-2027)
8.4.6 Gel Microdroplets
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2017-2021)
8.4.6.3 Forecast Trend (2022-2027)
8.4.7 Flow Cytometry
8.4.7.1 Market Share
8.4.7.2 Historical Trend (2017-2021)
8.4.7.3 Forecast Trend (2022-2027)
8.4.8 Others
8.5 Global RSV Diagnostics Market by End-Use
8.5.1 Hospitals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Laboratory
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Clinics
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Homecare
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.6 Global RSV Diagnostics Market by Region
8.6.1 Market Share
8.6.1.1 North America
8.6.1.2 Europe
8.6.1.3 Asia Pacific
8.6.1.4 Latin America
8.6.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Abbott Laboratories
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Thermo Fisher Scientific Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 F. Hoffmann-La Roche Ltd
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Becton, Dickinson and Company
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 bioMérieux SA
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 DiaSorin Molecular LLC
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Industry Events and Developments
List of Figures and Tables
1. Global RSV Diagnostics Market: Key Industry Highlights, 2017 and 2027
2. Global RSV Diagnostics Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global RSV Diagnostics Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global RSV Diagnostics Historical Market: Breakup by End-Use (USD Million), 2017-2021
5. Global RSV Diagnostics Market Forecast: Breakup by End-Use (USD Million), 2022-2027
6. Global RSV Diagnostics Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global RSV Diagnostics Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America RSV Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America RSV Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe RSV Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe RSV Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific RSV Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific RSV Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America RSV Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America RSV Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa RSV Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa RSV Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global RSV Diagnostics Market Structure
Key Questions Answered in the Report
The global RSV diagnostics market attained a value of nearly USD 846.96 million in 2021.
The market is projected to grow at a CAGR of 10.2% in the forecast period of 2022-2027.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 1516.89 million by 2027.
The market is being driven by the rising prevalence of RSV disorder, especially amongst children below the age of two and the resultant requirement for an effective diagnostic solution.
Improvements in diagnostics technology and robust investments into the research and development (R&D) activities are expected to aid the market growth in the coming years.
The major regional markets for RSV diagnostics are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The major products of RSV diagnostics are direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADT), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, and flow cytometry, among others.
The major end-uses of RSV diagnostics are hospitals, laboratory, clinics, and homecare.
The major players in the industry are Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, bioMérieux SA, and DiaSorin Molecular LLC, among others.
Analyst Review
The global RSV diagnostics market attained a value of about USD 846.96 million in 2021, driven by the rising prevalence of RSV disorders. Aided by large scale investment into the healthcare sector, the market is expected to grow at a CAGR of 10.2% in the forecast period of 2022-2027 to reach nearly USD 1516.89 million by 2027.
EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. On the basis of product, the market can be divided into direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADT), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, and flow cytometry, among others. Based on end-use, the market can be segmented into hospitals, laboratory, clinics, and homecare. The major regional markets for RSV diagnostics are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, bioMérieux SA, and DiaSorin Molecular LLC, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global veterinary diagnostic imaging market is driven by the growing prevalence of health-related issues in animals. Aided by the increasing use of veterinary diagnostic imaging in research activi...
The global urinalysis market attained a value of about USD 1.9 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 6.8% to reach nearly USD 2.8 bil...
The global dengue testing market attained a value of USD 456.2 million in 2020, driven by the rise in the number of dengue cases. Aided by increasing research and development related activities to dev...
The global clinical nutrition market attained a value of about USD 33.60 billion in 2020, driven by the rise in the prevalence of metabolic disorders. Aided by the high spending on healthcare and incr...
The global liquid biopsy market attained a value of about USD 1,250 million in 2020, driven by the rising prevalence of cancer. Aided by the growing technological advancements, the market is expected ...
NEWSLETTER